katrina4384Sep 14, 20231 min readNeurocrine Biosciences Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Application for INGREZZA (valbenazine) Oral Granules Sprinkle Formation
Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Application for INGREZZA (valbenazine) Oral Granules Sprinkle Formation
Myth or Fact: People with Psychiatric Symptoms in Huntington's Disease Won't Have Involuntary Movement
Prilenia filed a European Marketing Authorization Application (MAA) with the EMA. What's next for the United States?
Comentários